Site icon news.soban.in

Price cuts lift Novo Nordisk’s Wegovy share; Mounjaro still leads sales (Soban News)

Novo Nordisk cut Wegovy prices in mid-November, driving a 70% consumption jump and higher market share. Pharmarack data show Lilly’s Mounjaro still dominates sales​Novo Nordisk cut Wegovy prices in mid-November, driving a 70% consumption jump and higher market share. Pharmarack data show Lilly’s Mounjaro still dominates sales ​Latest News [ SOBAN NEWS: International and National ]

Exit mobile version